Related Experiment Video
Updated: Jan 31, 2026

07:12
Laminectomy for the Removal of Thoracic Ossification of the Ligamentum Flavum TOLF Using Ultrasonic and Conventional Osteotomes
Published on: April 21, 2023
3.4K
Hemostasis with the Ultrasonic Scalpel
Claudio Peixoto Crispi1, Claudio Peixoto Crispi1, Paulo Sergio da Silva Reis1
1Crispi Institute of Minimally Invasive Surgery, Rio de Janeiro, Brazil.
JSLS : Journal of the Society of Laparoendoscopic Surgeons
|January 11, 2019
Summary
The ultrasonic scalpel safely seals vessels up to 8 mm during laparoscopic surgery, even under high blood pressure. This surgical tool effectively prevents bleeding without additional hemostatic devices.
Area of Science:
- Surgical Technology
- Minimally Invasive Surgery
- Vascular Surgery
Background:
- The ultrasonic scalpel is a key instrument in minimally invasive surgery for vessel sealing.
- Assessing its safety and efficacy in sealing various vessel sizes under different blood pressure conditions is crucial.
Purpose of the Study:
- To evaluate the safety and feasibility of a laparoscopic ultrasonic scalpel.
- To determine the maximum vessel diameter safely sealed by the instrument in vivo.
- To assess performance under both physiological and supraphysiological blood pressure.
Main Methods:
- A single healthy female swine underwent omentum resection, liver biopsies, and hysterectomy.
- Vessels ranging from 2 to 10 mm were sealed using the ultrasonic scalpel.
- Procedures were conducted under normal hemodynamics and during pharmacologically induced hypertension.
Main Results:
- The ultrasonic scalpel was effective and rapid, with no bleeding in resected tissues.
- Vessels up to 8 mm were sealed without bleeding, even during sustained high blood pressure challenges.
- Bleeding occurred in one 10 mm common iliac vein and one 10 mm common iliac artery during testing.
Conclusions:
- The ultrasonic scalpel demonstrates safety in sealing arteries up to 8 mm during laparoscopic procedures.
- It effectively prevents or controls bleeding, even when blood pressure is elevated.
- The instrument shows high feasibility for use in complex laparoscopic surgeries.
Related Concept Videos
Disorders of Hemostasis
2.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.2K
Introduction to Hemostasis
14.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.1K
Extrinsic and Intrinsic Pathways of Hemostasis
12.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.7K

